SAN FRANCISCO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for ...

Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation Placebo-adjusted mean weight ...

Structure Therapeutics Inc. earns a Strong Buy rating following robust phase 2b data for oral GLP-1R agonist Aleniglipron in obesity. Aleniglipron achieved placebo-adjusted weight loss up to -15.3% at ...

Newer languages might soak up all the glory, but these die-hard languages have their place. Here are eight languages ...

Vitamin C has long been sold as a shortcut to a brighter complexion, but the latest research suggests it is doing something ...

The engagement establishes a multi-phase framework to support AI enabled capital efficient development of Teverelix, a next generation GnRH antagonist, as a first in class market product for acute ...

Chinese AI startup’s release is a major update to its open-source model series, aimed at multi-language programming and ...

The latest update is out from AXIA Energia Pfd Class B ( ($AXIA.PR) ).

Discover the top 7 programming languages of 2025 based on the TIOBE Index. Learn about the trends in Python, Java, C++, SQL, ...

Potential to bring nuclear power, scalable eSAF production, and environmental-attribute monetization together into a single, integrated clean-energy platform. Exploring advancing next-generation eSAF ...

Duplicates of crystal structures are flooding databases, implicating repositories hosting organic, inorganic, and computer-generated crystals. While some database administrators are mum about ...

Single-Parent Children, Family Therapy, Cognitive Behavioral Therapy (CBT), Emotional Dysregulation Share and Cite: Xue, Y.H. and Wang, L.H. (2025) Family Therapy Program for Children from ...